Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: Cancer and leukemia group B study 9473

Clinical Cancer Research

Volumn 5, Issue 12, 1999, Pages 3942-3947

  Burns, C Patrick ^a   Halabi, Susan ^b   Clamon, Gerald H ^a   Hars, Vera ^b   Wagner, Brett A ^a   Hohl, Raymond J ^a   Lester, Eric ^c   Kirshner, Jeffrey J ^d   Vinciguerra, Vincent ^e   Paskett, Electra ^f  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b CALGB Statistical Center   (United States)

^c LAKELAND REGIONAL MEDICAL CENTER   (United States)

^d SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^e NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ADULT; AGED; ARTICLE; CACHEXIA; CANCER CELL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONSTIPATION; DIARRHEA; DOSE RESPONSE; FECES INCONTINENCE; HUMAN; LEUKEMIA CELL; LIPID COMPOSITION; LYMPHOCYTE; NAUSEA; PRIORITY JOURNAL; STEATORRHEA; TUMOR GROWTH; VOMITING; XEROSTOMIA;

ADULT; AGED; BODY WEIGHT; CACHEXIA; CAPSULES; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 18544391450     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Karmali, R. A. Historical perspective and potential use of n-3 fatty acids in therapy of cancer cachexia. Nutrition, 12 (Suppl. 1): S2-S4,1996.
2. Tisdale, M. J. Biology of cachexia. J. Natl. Cancer Inst., 89: 1763-1773, 1997.
3. Tisdale, M. J., and Dhesi, J. K. Inhibition of weight loss by ω-3 fatty acids in an experimental cachexia model. Cancer Res., 50: 5022-5026, 1990.
4. Beck, S. A., Smith, K. L., and Tisdale, M. J. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res., 51: 6089-6093, 1991.
5. Dagnelie, P. C., Bell, J. D., Williams, S. C., Bates, T. E., Abel, P. D., and Foster, C. S. Effect of fish oil on cancer cachexia and host liver metabolism in rats with prostate tumors. Lipids, 29: 195-203, 1994.
6. Todorov, P., Cariuk, P., McDevitt, T., Coles. B., Fearon, K., and Tisdale, M. Characterization of a cancer cachectic factor. Nature (Lond.), 379: 739-742, 1996.
7. Wigmore, S. J., Ross, J. A., Falconer, J. S., Plester, C. E., Tisdale, M. J., Carter, D. C., and Fearon, K. C. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition, 12: S27-S30, 1996.
8. Burns, C. P., and Wagner, B. A. Effects of exogenous lipids on cancer and cancer chemotherapy: implications for treatment. Drug Safety., 8: 57-68, 1993.
9. Burns, C. P., and Spector, A. A. Biochemical effects of lipids on cancer therapy. J. Nutr. Biochem., 5: 114-123, 1994.
10. Spector, A. A., and Burns, C. P. Perspectives in cancer research: biological and therapeutic potential of membrane lipid modification in tumors. Cancer Res., 47: 4529-4539, 1987.
11. Penta, J. S., Rosner, G. L., and Trump, D. L. Choice of starting dose and escalation for Phase I studies of antitumor agents. Cancer Chemother. Pharmacol., 31: 247-250, 1992.
12. Burns, C. P., and Wagner, B. A. Heightened susceptibility of fish oil polyunsaturate-enriched neoplastic cells to ethane generation during lipid peroxidation. J. Lipid Res., 32: 79-87, 1991.
13. Burns, C. P., Petersen, E. S., North, J. A., and Ingraham, L. M. Effect of docosahexaenoic acid on rate of differentiation of HL-60 human leukemia. Cancer Res., 49: 3252-3258, 1989.
14. Lee, T. H., Hoover, R. L., Williams, J. D., Sperling, R. I., Ravalese, J. D., Spur, B. W., Robinson, D. R., Corey, E. J., Lewis, R. A., and Austen, K. F. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med., 312: 1217-1224, 1985.
15. Tisdale, M. J., and Beck, S. A. Inhibition of tumour-induced lipolysis in vitro and cachexia and tumour growth in vivo by eicosapentaenoic acid. Biochem. Pharmacol., 41: 103-107, 1991.
16. Gogos, C. A., Ginopoulos, P., Salsa, B., Apostolidou, E., Zoumbos, N. C., and Kalfarentzos, F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer (Phila.), 82: 395-402, 1998.
17. Holroyde, C. P., Skutches, C. L., and Reichard, G. A. Effect of dietary enrichment of N-3 polyunsaturated fatty acids (PUFA) in metastatic breast cancer. Proc. Soc. Clin. Oncol., 7: 42, 1988.
18. Krokan, H. E., Bjerve, K. S., and Mork, E. The enterai bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro. Biochim. Biophys. Acta, 1168: 59-67, 1993.
19. Knapp, H. R., Reilly, I. A., Alessandrini, P., and FitzGerald, G. A. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N. Engl. J. Med., 314: 937-942, 1986.
20. Knapp, H. R., and FitzGerald, G. A. The antihypertensive effects of fish oil: a controlled study of polyunsaturated fatty acid supplements in essential hypertension. N. Engl. J. Med., 320: 1037-1043, 1989.
21. Braden, G. A., Knapp, H. R., and FitzGerald, G. A. Suppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin. Circulation, 84: 679-685, 1991.
22. Wagner, B. A., Buettner, G. R., and Burns, C. P. Free radical-mediated lipid peroxidation in cells: oxidizability is a function of cell lipid bis-allylic hydrogen content. Biochemistry, 33: 4449-4453, 1994.